LowClass IIITerminated

FDA Drug recall · Reported December 6, 2017

Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Goa 403 722 India, NDC 68180-295-06, UPC 368180295068

Q: Which agency issued this recall?

This recall was issued by the FDA Drug on December 6, 2017. Severity: Low. Recall number: D-0097-2018.

Q: Where was the recalled product distributed?

Distribution: Nationwide within the United States.

Q: Should I stop using a recalled medication or medical device?

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Failed Dissolution Specification

Recall #: D-0097-2018
Affected scope: 111,648 units
Initiated: November 21, 2017

Compiled from official public sources by the publisher. · Updated September 2026

Verify with FDA Drug →

View my saved recalls

Lupin Pharmaceuticals Inc. recalled Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured f… - a low-severity action.

Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured f… was recalled by Lupin Pharmaceuticals Inc. in December 6, 2017. Reason: Failed Dissolution Specification. Check the official notice for the remedy. Verify recall #D-0097-2018 with the FDA Drug before acting.

The recall

Lupin Pharmaceuticals Inc. issued this low-severity FDA Drug recall-Failed Dissolution Specification.

Low
severity level: 112K units
affected scope: Class III
classification: December 6, 2017
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0097-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope (see the Recall Profile below) is large enough to require multi-state distribution tracking. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Goa 403 722 India, NDC 68180-295-06, UPC 368180295068

Reason for recall

Failed Dissolution Specification

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Low (Class III)
Status	Terminated
Recall number	D-0097-2018
Date reported	December 6, 2017
Date initiated	November 21, 2017
Recalling firm	Lupin Pharmaceuticals Inc.
Firm location	Baltimore, MD
Affected scope	111,648 units
Distribution	Nationwide within the United States

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

Scale of Impact

111,648 units units affected - multi-state distribution scale.

Regional (<10K units) -

Multi-state (10K – 100K units) -

Large-scale (100K – 1M units) ✓ This recall

Massive (≥1M units) -

Bracket cutoffs follow federal recall-disclosure conventions; bar widths scale linearly within each bracket. Source: PlainRecalls analysis of U.S. Food and Drug Administration filings.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-0097-2018) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Why was this product recalled? ▼

Failed Dissolution Specification

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on December 6, 2017. Severity: Low. Recall number: D-0097-2018.

Where was the recalled product distributed? ▼

Distribution: Nationwide within the United States.

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Low), closest by report date among other firms and states.

Maple Hill Creamery, Fiore Di Latte Fres… 2017-12-06 Pure Encapsulations Systemic Enzyme Compl… 2017-12-06 pure encapsulations AI Enzymes DIETARY SU… 2017-12-06 Ian's Gluten Free Original Panko Breadcru… 2017-12-06

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Clozapine Tablets USP, 100 mg, 500 count … 2017-12-06 Liothyronine Sodium Tablets, USP 25 mcg ,… 2017-12-06 Levetiracetam Oral Solution, USP, 100 mg/… 2017-12-06 Berry Flavor Immune Support Dietary Suppl… 2017-12-06

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported December 6, 2017. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026